TY  - JOUR
T1  - Childhood acute myeloid leukaemia
AU  - Krstovskı, Nada
AU  - Janıc, Dragana
AU  - Dokmanovıc, Lidija
PY  - 2010
DA  - June
DO  - 10.17334/jps.22285
JF  - Journal of Pediatric Sciences
PB  - Bilal YILDIZ
WT  - DergiPark
SN  - 1309-1247
SP  - 0
VL  - 2
IS  - 3
LA  - en
AB  - Over past decades, remarkable progress has been made in the treatment and in the understanding of the molecular pathogenesis of acute myeloid leukaemia (AML). At present, up to 65% of paediatric AML patients experience long term survival, owing to more effective use of antileukaemic therapy, improvements in supportive care and better risk stratification. However significant challenges remain including better methods to predict which patients can be cured and which one need more intensive therapy. This brief review describes well established biologic features and clinical parameters, risk stratifications, prognostic factors and current approach in treatment strategies.
KW  - acute myeloid leukaemia
KW  - children
KW  - diagnosis
KW  - therapy
UR  - https://doi.org/10.17334/jps.22285
L1  - https://dergipark.org.tr/tr/download/article-file/178803
ER  -